Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer-related Molecular Pathways, Cancer Genomics and Diagnostics, Bioinformatics and Genomic Networks, and Computational Drug Discovery Methods.
Benefit of the N-of-1 Approach Versus Aggregate Analysis in Tracking Individual Trajectories During Pregnancy: Comparison of Longitudinal Wearable Observational Studies.
Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.
Detecting and Remediating Harmful Data Shifts for the Responsible Deployment of Clinical AI Models
CANAIRI: the Collaboration for Translational Artificial Intelligence Trials in healthcare
What makes a ‘good’ decision with artificial intelligence? A grounded theory study in paediatric care
Maternal health Aggregated Trends can be Misleading: The power of N-of-1 Level Wearable Data Analysis for Personalized Pregnancy Monitoring
Maternal health Aggregated Trends can be Misleading: The power of N-of-1 Level Wearable Data Analysis for Personalized Pregnancy Monitoring (Preprint)
Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study (Preprint)
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA.
Table S1 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S6 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S1 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S5 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S6 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S2 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S2 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S2 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S5 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Data from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S2 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S6 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Data from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S9 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S7 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S11 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S9 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S12 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S8 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Figure S12 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA
Table S6 from Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA